To explore the possible role of CA12 in tumor-associated monocytes and macrophages, we treated peripheral CD14+ cells with HepG2 TSN in the presence of negative control siRNA (siNC), CA12 siRNA (siCA12). The gene discussed is CA12; the disease is neoplasm.